Alto Neuroscience (ANRO) Other Operating Expenses (2023)
Alto Neuroscience (ANRO) reported Other Operating Expenses of $30.1 million for Q4 2023.
Alto Neuroscience (ANRO) Other Operating Expenses (2023) Analysis & Trends
Alto Neuroscience (ANRO) has 1 years of Other Operating Expenses data on file, last reported at $30.1 million in Q4 2023.
- For the quarter ending Q4 2023, Other Operating Expenses changed N/A year-over-year to $30.1 million; the trailing twelve-month figure through Sep 2024 stood at $30.1 million (changed N/A YoY), and the FY2023 full-year result was $30.1 million, changed N/A from the prior year.
- Other Operating Expenses was little changed at $30.1 million in Q4 2023.
- In the past five years, Other Operating Expenses ranged from a high of $30.1 million in Q4 2023 to a low of $30.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alto Neuroscience | 869.36 Mn | 869.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 30.09 Mn |